Challenges in the treatment of tuberculosis
Registration for this session is additional to the congress registration fee and is €171 on site, €153 standard.
Aims : Access educational materials here To help clinicians to confidently manage all tuberculosis patients with the aim of achieving tuberculosis elimination in Europe and elsewhere; to help clinicians treat tuberculosis in patients with whom failure of treatment or adherence could result in drug resistance; and to address concerns regarding heart rate-corrected QT interval (QTc) prolongation with current second-line drugs.
Target audience :
Critical/Intensive care physician, Paediatrician, Trainee, Adult pulmonologist/Clinician